This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1987 Jun;14(2):67-86.

doi: 10.1016/0305-7372(87)90041-7.

Mesna--a short review

I C Shaw¹, M I Graham

Affiliations

PMID: 3119211
DOI: 10.1016/0305-7372(87)90041-7

Review

Mesna--a short review

I C Shaw et al. Cancer Treat Rev. 1987 Jun.

. 1987 Jun;14(2):67-86.

doi: 10.1016/0305-7372(87)90041-7.

Authors

I C Shaw¹, M I Graham

Affiliation

¹ Toxicology Laboratory, University College London, U.K.

PMID: 3119211
DOI: 10.1016/0305-7372(87)90041-7

No abstract available

PubMed Disclaimer

Similar articles

Mesna and oxazaphosphorine cancer chemotherapy.
Shaw IC. Shaw IC. Cancer Treat Rev. 1987 Dec;14(3-4):359-64. doi: 10.1016/0305-7372(87)90030-2. Cancer Treat Rev. 1987. PMID: 3125971 No abstract available.
Clinical overview of mesna.
Burkert H. Burkert H. Cancer Treat Rev. 1983 Sep;10 Suppl A:175-81. doi: 10.1016/s0305-7372(83)80026-7. Cancer Treat Rev. 1983. PMID: 6414692 Clinical Trial.
The development of mesna for regional detoxification.
Brock N, Pohl J. Brock N, et al. Cancer Treat Rev. 1983 Sep;10 Suppl A:33-43. doi: 10.1016/s0305-7372(83)80005-x. Cancer Treat Rev. 1983. PMID: 6414694 No abstract available.
[Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
Schmähl D, Habs M, Tacchi AM. Schmähl D, et al. Urologe A. 1984 Sep;23(5):291-6. Urologe A. 1984. PMID: 6438859 German.
Ifosfamide and mesna.
Schoenike SE, Dana WJ. Schoenike SE, et al. Clin Pharm. 1990 Mar;9(3):179-91. Clin Pharm. 1990. PMID: 2107997 Review.

See all similar articles

Cited by

Oral bioavailability of mesna tablets.
Stofer-Vogel B, Cerny T, Borner M, Lauterburg BH. Stofer-Vogel B, et al. Cancer Chemother Pharmacol. 1993;32(1):78-81. doi: 10.1007/BF00685881. Cancer Chemother Pharmacol. 1993. PMID: 8462128
Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review.
Cauli O. Cauli O. Antioxidants (Basel). 2021 Jul 13;10(7):1116. doi: 10.3390/antiox10071116. Antioxidants (Basel). 2021. PMID: 34356349 Free PMC article.
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.
Kerbusch T, de Kraker J, Keizer HJ, van Putten JW, Groen HJ, Jansen RL, Schellens JH, Beijnen JH. Kerbusch T, et al. Clin Pharmacokinet. 2001 Jan;40(1):41-62. doi: 10.2165/00003088-200140010-00004. Clin Pharmacokinet. 2001. PMID: 11236809 Review.
Dosing and side-effects of ifosfamide plus mesna.
Brade WP, Herdrich K, Kachel-Fischer U, Araujo CE. Brade WP, et al. J Cancer Res Clin Oncol. 1991;117 Suppl 4(Suppl 4):S164-86. doi: 10.1007/BF01613224. J Cancer Res Clin Oncol. 1991. PMID: 1795007 Free PMC article. Review.
False-positive ketone tests: a bedside measure of urinary mesna.
Goren MP, Pratt CB. Goren MP, et al. Cancer Chemother Pharmacol. 1990;25(5):371-2. doi: 10.1007/BF00686240. Cancer Chemother Pharmacol. 1990. PMID: 2106398

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database